175 related articles for article (PubMed ID: 34681615)
1. Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin.
Efentakis P; Psarakou G; Varela A; Papanagnou ED; Chatzistefanou M; Nikolaou PE; Davos CH; Gavriatopoulou M; Trougakos IP; Dimopoulos MA; Andreadou I; Terpos E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681615
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.
Efentakis P; Kremastiotis G; Varela A; Nikolaou PE; Papanagnou ED; Davos CH; Tsoumani M; Agrogiannis G; Konstantinidou A; Kastritis E; Kanaki Z; Iliodromitis EK; Klinakis A; Dimopoulos MA; Trougakos IP; Andreadou I; Terpos E
Blood; 2019 Feb; 133(7):710-723. PubMed ID: 30482794
[TBL] [Abstract][Full Text] [Related]
3. Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib.
Efentakis P; Doerschmann H; Witzler C; Siemer S; Nikolaou PE; Kastritis E; Stauber R; Dimopoulos MA; Wenzel P; Andreadou I; Terpos E
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707866
[TBL] [Abstract][Full Text] [Related]
4. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
5. Rutin Attenuates Carfilzomib-Induced Cardiotoxicity Through Inhibition of NF-κB, Hypertrophic Gene Expression and Oxidative Stress.
Imam F; Al-Harbi NO; Al-Harbia MM; Korashy HM; Ansari MA; Sayed-Ahmed MM; Nagi MN; Iqbal M; Khalid Anwer M; Kazmi I; Afzal M; Bahashwan S
Cardiovasc Toxicol; 2017 Jan; 17(1):58-66. PubMed ID: 26707720
[TBL] [Abstract][Full Text] [Related]
6. Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats.
Imam F; Al-Harbi NO; Al-Harbi MM; Ansari MA; Almutairi MM; Alshammari M; Almukhlafi TS; Ansari MN; Aljerian K; Ahmad SF
Toxicol Mech Methods; 2016 Nov; 26(9):700-708. PubMed ID: 27785949
[TBL] [Abstract][Full Text] [Related]
7. Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.
Efentakis P; Varela A; Lamprou S; Papanagnou ED; Chatzistefanou M; Christodoulou A; Davos CH; Gavriatopoulou M; Trougakos I; Dimopoulos MA; Terpos E; Andreadou I
Br J Pharmacol; 2024 Apr; ():. PubMed ID: 38679957
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanisms of the Cardiotoxicity of the Proteasomal-Targeted Drugs Bortezomib and Carfilzomib.
Hasinoff BB; Patel D; Wu X
Cardiovasc Toxicol; 2017 Jul; 17(3):237-250. PubMed ID: 27388042
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the human 20S proteasome in complex with carfilzomib.
Harshbarger W; Miller C; Diedrich C; Sacchettini J
Structure; 2015 Feb; 23(2):418-24. PubMed ID: 25599644
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
[TBL] [Abstract][Full Text] [Related]
11. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
12. AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction.
Turdi S; Fan X; Li J; Zhao J; Huff AF; Du M; Ren J
Aging Cell; 2010 Aug; 9(4):592-606. PubMed ID: 20477759
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy.
Iannaccone A; Bruno G; Ravera A; Gay F; Salvini M; Bringhen S; Sabia L; Avenatti E; Veglio F; Milan A
High Blood Press Cardiovasc Prev; 2018 Jun; 25(2):209-218. PubMed ID: 29582365
[TBL] [Abstract][Full Text] [Related]
14. XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
Turner JG; Kashyap T; Dawson JL; Gomez J; Bauer AA; Grant S; Dai Y; Shain KH; Meads M; Landesman Y; Sullivan DM
Oncotarget; 2016 Nov; 7(48):78896-78909. PubMed ID: 27806331
[TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity with carfilzomib at doses greater than 27 mg/m
Kim GY; Ahuja T; Papadopoulos J; Cirrone F
J Oncol Pharm Pract; 2019 Jan; 25(1):229-233. PubMed ID: 28914153
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
17. Metformin attenuates sevoflurane-induced neurocognitive impairment through AMPK-ULK1-dependent autophagy in aged mice.
Jinpiao Z; Zongze Z; Qiuyue Y; Peng F; Qi Z; Yanlin W; Chang C
Brain Res Bull; 2020 Apr; 157():18-25. PubMed ID: 32014566
[TBL] [Abstract][Full Text] [Related]
18. Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction.
Li J; Gui Y; Ren J; Liu X; Feng Y; Zeng Z; He W; Yang J; Dai C
Sci Rep; 2016 Apr; 6():23975. PubMed ID: 27052588
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.
Shen X; Wu C; Lei M; Yan Q; Zhang H; Zhang L; Wang X; Yang Y; Li J; Zhu Y; Chen L
Cell Death Dis; 2021 Apr; 12(5):429. PubMed ID: 33931582
[TBL] [Abstract][Full Text] [Related]
20. Carfilzomib Triggers Cell Death in Chronic Lymphocytic Leukemia by Inducing Proapoptotic and Endoplasmic Reticulum Stress Responses.
Lamothe B; Wierda WG; Keating MJ; Gandhi V
Clin Cancer Res; 2016 Sep; 22(18):4712-26. PubMed ID: 27026200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
